FIELD: medicine. SUBSTANCE: invention proposes the use of human fetal liver tissue suspension as an agent for hyperlipidemia correction. EFFECT: enhanced effectiveness of an agent. 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD TO CORRECT LIPID PEROXIDE OXIDATION IN PATIENTS SUFFERING ISCHEMIC CARDIAC DISEASE | 1999 |
|
RU2178704C2 |
AGENT WITH HYPOLIPIDEMIC ACTIVITY | 2004 |
|
RU2268714C1 |
METHOD FOR TREATING CHRONIC PERIODONTITIS | 1999 |
|
RU2161920C1 |
MEDIUM FOR CONSERVATION OF SPLENIC CELLS | 2001 |
|
RU2194753C2 |
METHOD OF DETERMINING INDICATIONS FOR PERFORMING EFFERENT THERAPY | 1996 |
|
RU2163018C2 |
HYPOLIPIDEMIC AGENT | 2008 |
|
RU2392933C2 |
METHOD FOR MODELING GASTRODUODENITIS ASSOCIATED WITH HYPERLIPEMIA | 1999 |
|
RU2195024C2 |
METHOD OF TREATMENT OF PATIENTS WITH CALCULOUS CHOLECYSTITIS | 1997 |
|
RU2129026C1 |
METHOD FOR AUTOTRANSPLANTATION OF SPLENIC TISSUES | 1994 |
|
RU2112429C1 |
METHOD FOR PREPARING SKIN COVER DEFECT TO AUTODERMOPLASTY OPERATION | 2000 |
|
RU2192266C2 |
Authors
Dates
1998-06-10—Published
1995-07-20—Filed